Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort
HIV Medicine,Volume 19, Issue 4, Page 252-260, April 2018. (Source: HIV Medicine)
Source: HIV Medicine - December 22, 2017 Category: Infectious Diseases Source Type: research
---
HIV Medicine, Ahead of Print. (Source: HIV Medicine)
Source: HIV Medicine - December 22, 2017 Category: Infectious Diseases Source Type: research
Efficacy, safety and patient ‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)
ConclusionsLDV/SOF provided a high SVR rate in PI‐experienced subjects coinfected with HCV genotype 1 and HIV‐1, including patients with cirrhosis. (Source: HIV Medicine)
Source: HIV Medicine - December 7, 2017 Category: Infectious Diseases Authors: E Rosenthal, C Fougerou ‐Leurent, A Renault, MP Carrieri, F Marcellin, R Garraffo, E Teicher, H Aumaitre, K Lacombe, F Bailly, E Billaud, S Chevaliez, S Dominguez, MA Valantin, J Reynes, A Naqvi, L Cotte, S Metivier, V Leroy, M Dupon, T Allegre, P De Tr Tags: Original Research Source Type: research
---
HIV Medicine,Volume 19, Issue 3, Page 227-237, March 2018. (Source: HIV Medicine)
Source: HIV Medicine - December 7, 2017 Category: Infectious Diseases Source Type: research
Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in HIV ‐positive and HIV‐negative women in Rwanda
ConclusionsThe currently used quadrivalent vaccine may be insufficient to give satisfactory HPV coverage in Rwanda. HPV Screening may be effective to identify women at risk of developing cervical cancer, particularly if provided to high‐risk patients. (Source: HIV Medicine)
Source: HIV Medicine - December 6, 2017 Category: Infectious Diseases Authors: MF Mukanyangezi, V Sengpiel, O Manzi, G Tobin, S Rulisa, E Bienvenu, D Giglio Tags: Original Research Source Type: research
---
HIV Medicine,Volume 19, Issue 3, Page 206-215, March 2018. (Source: HIV Medicine)
Source: HIV Medicine - December 6, 2017 Category: Infectious Diseases Source Type: research
HbAHP ‐25 attenuates HIV‐1 gp120 mediated inflammation and barrier dysfunction
ConclusionHbAHP‐25 is exceedingly safe to genital epithelial cells and attenuates HIV‐1 gp120‐mediated barrier dysfunction by limiting excessive inflammation. This study provides significant evidences in the favor of HbAHP‐25's potential as a topical anti‐HIV agent. (Source: HIV Medicine)
Source: HIV Medicine - December 6, 2017 Category: Infectious Diseases Authors: T Bashir, KVR Reddy Tags: Original Research Source Type: research
Issue Information
(Source: HIV Medicine)
Source: HIV Medicine - December 4, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research
---
HIV Medicine,Volume 19, Issue 3, Page 216-226, March 2018. (Source: HIV Medicine)
Source: HIV Medicine - December 1, 2017 Category: Infectious Diseases Source Type: research
---
HIV Medicine,Volume 19, Issue 3, Page 184-194, March 2018. (Source: HIV Medicine)
Source: HIV Medicine - December 1, 2017 Category: Infectious Diseases Source Type: research
Management of drug interactions with direct ‐acting antivirals in Dutch HIV/hepatitis C virus‐coinfected patients: adequate but not perfect
ConclusionsPrescription patterns suggest that physicians are aware of potential DDIs between co‐medication and DAAs, in particular potential DDIs with cART. Greater awareness is needed concerning category 3 interactions between non‐cART co‐medication and DAAs. (Source: HIV Medicine)
Source: HIV Medicine - December 1, 2017 Category: Infectious Diseases Authors: EJ Smolders, C Smit, CTMM Kanter, ASM Dofferhoff, JE Arends, K Brinkman, B Rijnders, M Valk, P Reiss, DM Burger, Tags: Original Research Source Type: research
Pre ‐exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population
HIV Medicine,Volume 19, Issue 4, Page 243-251, April 2018. (Source: HIV Medicine)
Source: HIV Medicine - November 27, 2017 Category: Infectious Diseases Source Type: research
---
HIV Medicine, Ahead of Print. (Source: HIV Medicine)
Source: HIV Medicine - November 27, 2017 Category: Infectious Diseases Source Type: research
---
HIV Medicine,Volume 19, Issue 3, Page 195-205, March 2018. (Source: HIV Medicine)
Source: HIV Medicine - November 23, 2017 Category: Infectious Diseases Source Type: research
---
HIV Medicine,Volume 19, Issue 3, Page 175-183, March 2018. (Source: HIV Medicine)
Source: HIV Medicine - November 21, 2017 Category: Infectious Diseases Source Type: research
